Pharmacy benefit managers (PBM) sit at the center of a rapidly shifting regulatory landscape, and employers can no longer afford to take their PBM contracts at face value. In this follow-up episode of Mobility via Podcast, we explore the DOL's new disclosure rules and the Consolidated Appropriations Act of 2026, which mandate 100% rebate pass-through, semi-annual reporting, and civil penalties for non-compliance. We also cover the growing litigation targeting plan sponsors for failing to benchmark pricing, conduct competitive RFPs, and rein in spread pricing. Finally, we discuss why many employers are transitioning to transparent, pass-through PBM models — and how doing so has driven 10–25% per-capita pharmacy cost reductions in year one.
Meet our podcast team